Cargando…

The Outcomes of Hypertransfusion in Major ABO Incompatible Allogeneic Stem Cell Transplantation

Major ABO incompatibility may be potentially associated with immediate or delayed hemolysis and delayed onset of erythropoiesis in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). To determine if hemolysis can be prevented by the inhibition of graft erythropoiesis, we pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Se Hoon, Lee, Mark Hong, Lee, Se Hoon, Lee, Kyung-Eun, Park, Jinny, Park, Joon Oh, Kim, Kihyun, Kim, Won Seog, Jung, Chul Won, Im, Young-Hyuk, Kang, Won Ki, Park, Keunchil, Kim, Seon Woo, Lee, Kyoo Hyung, Lee, Je Hwan
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2004
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822268/ https://www.ncbi.nlm.nih.gov/pubmed/14966346 http://dx.doi.org/10.3346/jkms.2004.19.1.79

Ejemplares similares

Influence of Transfusion on the Risk of Acute Kidney Injury: ABO-Compatible versus ABO-Incompatible Liver Transplantation
por: Yu, Je Hyuk, et al.
Publicado: (2019)

Pulmonary Complications After Hematopoietic Stem Cell Transplantation
por: Lim, Do Hyoung, et al.
Publicado: (2006)

Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation
por: Park, Woo Yeong, et al.
Publicado: (2016)

The use of polytetrafluoroethylene graft for damaged renal artery in ABO-incompatible living donor kidney transplantation: a case report
por: Chang, Won-Bae, et al.
Publicado: (2022)

Clinical Impact of Recipient-Derived Isoagglutinin Levels in ABO-Incompatible Hematopoietic Stem Cell Transplantation
por: Nam, Minjeong, et al.
Publicado: (2023)

Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea
por: Jang, Jun Ho, et al.
Publicado: (2020)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission
por: Lee, Je-Hwan, et al.
Publicado: (2010)

Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation
por: Kim, A Young, et al.
Publicado: (2021)

Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations
por: Ko, Youngmin, et al.
Publicado: (2020)

Perioperative ABO Blood Group Isoagglutinin Titer and the Risk of Acute Kidney Injury after ABO-Incompatible Living Donor Liver Transplantation
por: Cho, Hyeyeon, et al.
Publicado: (2021)

Role of Plasma Exchange in ABO-incompatible Kidney Transplantation
por: Yoo, Soohun, et al.
Publicado: (2012)

Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA–Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis
por: Kim, Seung Tae, et al.
Publicado: (2017)

Hypertransfusion Therapy in Sickle Cell Disease in Nigeria
por: Adewoyin, Ademola Samson, et al.
Publicado: (2014)

Hemorrhagic cystitis following allogeneic hematopoietic cell transplantation.
por: Lee, Gyeong-Won, et al.
Publicado: (2003)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)

Prevalent metabolic derangement and severe thrombocytopenia in ABO-incompatible liver recipients with pre-transplant plasma exchange
por: Kwon, Hye-Mee, et al.
Publicado: (2018)

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
por: Lim, Sung Hee, et al.
Publicado: (2016)

BK virus encephalitis without concurrent hemorrhagic cystitis in an allogeneic hematopoietic stem cell transplant recipient
por: Lee, Suk-young, et al.
Publicado: (2013)

Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation
por: Park, Silvia, et al.
Publicado: (2016)

Is immunological recovery clinically relevant at 100 days after allogeneic transplantation?
por: Park, Jin, et al.
Publicado: (2020)

The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors
por: Kim, Moonjin, et al.
Publicado: (2016)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis
por: Chae, Min Suk, et al.
Publicado: (2018)

Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: A network meta-analysis
por: Lee, Hee Ryong, et al.
Publicado: (2021)

Comparative Analysis of Spontaneous Infectious Spondylitis : Pyogenic versus Tuberculous
por: Lee, Yangwon, et al.
Publicado: (2018)

Demineralized Bone Matrix (DBM) as a Bone Void Filler in Lumbar Interbody Fusion: A Prospective Pilot Study of Simultaneous DBM and Autologous Bone Grafts
por: Kim, Bum-Joon, et al.
Publicado: (2017)

First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients
por: Kim, Seung Tae, et al.
Publicado: (2020)

Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center’s experiences
por: Cho, Minho, et al.
Publicado: (2017)

Adenocarcinoma of Unknown Primary Site
por: Song, Seo Young, et al.
Publicado: (2002)

Sexuality and Quality of Life after Hematopoietic Stem Cell Transplantation
por: Lee, Hong Ghi, et al.
Publicado: (2002)

Adult Living Donor Liver Transplantation Across ABO-Incompatibility
por: Lee, Chen-Fang, et al.
Publicado: (2015)

ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer
por: Lee, Boram, et al.
Publicado: (2019)

Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial
por: Lim, Sung Won, et al.
Publicado: (2018)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis
por: Lee, Eung Chang, et al.
Publicado: (2017)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
por: Lee, Boram, et al.
Publicado: (2020)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2023)

To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients
por: Lee, Hansang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gijbnooe3of3gi5r8a0t2rdads